Authors
Latest:
Gonadotropin-Releasing Hormone Antagonists in Prostate CancerThis article reviews the mechanism of action between GnRH agonists and antagonists and the studies that led to the approval of degarelix, as well as its potential risks and benefits, particularly when it comes to cardiovascular health.
Latest:
Gonadotropin-Releasing Hormone Antagonists in Prostate CancerThis article reviews the mechanism of action between GnRH agonists and antagonists and the studies that led to the approval of degarelix, as well as its potential risks and benefits, particularly when it comes to cardiovascular health.
Latest:
Managing Afib in Cancer Patients Taking BTK InhibitorsCancer Network speaks with Dr. Leon Ptaszek about managing cancer patients who have atrial fibrillation and are being treated with BTK inhibitors.
Latest:
KATHERINE Results Back New Adjuvant Standard for HER2+ Breast CancerDr. Charles Geyer discusses the phase III KATHERINE trial, which compared ado-trastuzumab emtansine vs trastuzumab in HER2-positive early breast cancer.
Latest:
Targeting PI3K Remains Complex in Cancer TherapyDr. Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the importance of managing ambient insulin levels during therapy.
Latest:
Interrogating Ras-ERK Interactions and Roles in Tumor Cell BiologyCancer Network spoke with Dr. Chuan-Hsiang Huang about his lab’s research on Ras-ERK protein interactions within cancer cells.
Latest:
Identifying Cancer-Driving Gene MutationsCancer Network spoke with Dr. Rachel Karchin about the contemporary search for cancer-driving gene mutations.
Latest:
Promising Glioma Therapy OptionsDr. James Perry speaks with Cancer Network about glioma therapy options and the future of brain cancer treatment.
Latest:
Discussing Advances in Chemo Brain TreatmentCancer Network spoke with Tracy D. Vannorsdall, PhD and Patricia Ganz, MD about treatment methods for cancer-related cognitive impairment.
Latest:
Discussing Advances in Chemo Brain TreatmentCancer Network spoke with Tracy D. Vannorsdall, PhD and Patricia Ganz, MD about treatment methods for cancer-related cognitive impairment.
Latest:
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial CancerIn this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.
Latest:
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial CancerIn this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.
Latest:
Current Strategies for the Management of Locoregional Breast Cancer RecurrenceIn this review, we focus primarily on describing locoregional and systemic management strategies for isolated locoregional recurrences manifesting as isolated first-failure events following mastectomy or breast-conserving therapy.
Latest:
Current Strategies for the Management of Locoregional Breast Cancer RecurrenceIn this review, we focus primarily on describing locoregional and systemic management strategies for isolated locoregional recurrences manifesting as isolated first-failure events following mastectomy or breast-conserving therapy.
Latest:
Vitamin D and Omega-3 Supplements for Preventing Cancer and Other Chronic DiseasesDr. Manson discusses the results of the recently published VITAL study that tested whether vitamin D or omega-3 supplements could be effective for primary prevention of cancer and cardiovascular disease.
Latest:
Naval Daver, MD on Phase 1/2 Trial of DSP-5336 in R/R Acute LeukemiaA phase 1/2 trial assessed the use of menin inhibitor DSP-5336 in patients with acute leukemia overexpressing HOXA9 and MEIS1.
Latest:
Early Access to Electronic Health Records May Influence the Patient ExperienceIn a recent Hot Topics column, Mehmet Sitki Copur, MD, FACP, et al discussed the pros and cons of patients receiving test results early through electronic medical records.
Latest:
Locally Advanced Rectal Cancer, What is the Standard of Care?A 39-year-old Hispanic male presented with complaints of mucous stools, loss of appetite, rectal bleeding and a 30-pound weight loss within the past several months.
Latest:
Management of Neutropenic Toxicity From CDK4/6 InhibitorsAn oncology pharmacist discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer.
Latest:
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial CancerIn this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.
Latest:
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial CancerIn this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.
Latest:
Using Radiation Therapy to Reduce Recurrence in DCISCancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research.
Latest:
Adjuvant Durvalumab Beneficial in Esophageal/GEJ Cancer?Cancer Network spoke with Dr. Hirva Mamdani about the role and efficacy of adjuvant durvalumab in patients with Esophageal/GEJ Cancer.
Latest:
Perioperative Immunotherapy the Future of HCC Treatment?Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Latest:
Endoscopic Resection Brings Excitement to Esophageal Cancer TreatmentCancer Network spoke with Dr. Daniela Molena about the advancements in the treatment of esophageal cancer, including the safety and importance of endoscopic resection for the disease.
Latest:
The Next Steps Beyond Cytotoxic Chemo in Pancreatic CancerCancer Network spoke with Dr. Bassel El-Rayes about novel strategies on the horizon for pancreatic cancer during the 2019 ASCO Gastrointestinal Cancers Symposium.
Latest:
Does Vitamin D Have a Role in Cancer Prevention?Cancer Network spoke with Dr. Michael Holick about the role of and effectiveness of vitamin D in cancer prevention.
Latest:
Nausea and Vomiting: Managing Side Effects From PARP InhibitorsHere, two oncology pharmacists discuss the side effects of PARP inhibitor treatment, and how to prevent and treat nausea and vomiting in this patient population.
Latest:
Nausea and Vomiting: Managing Side Effects From PARP InhibitorsHere, two oncology pharmacists discuss the side effects of PARP inhibitor treatment, and how to prevent and treat nausea and vomiting in this patient population.
Latest:
CAR T-Cell Therapy in Non-Hodgkin Lymphoma PatientsDr. Copelan discusses the use of chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin lymphoma patients and how these therapies might improve upon the current standard of care.
